TC
Tavio Capital Portfolio holdings
AUM
$75.4M
This Quarter Return
+5.29%
1 Year Return
+27.99%
3 Year Return
+81.43%
5 Year Return
–
10 Year Return
–
AUM
$183M
AUM Growth
+$183M
(-25%)
Cap. Flow
-$68M
Cap. Flow
% of AUM
-37.08%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
13
New
3
Increased
1
Reduced
3
Closed
5
Top Buys
| 1 |
Cencora
COR
|
$35.3M |
| 2 |
CVS Health
CVS
|
$24.5M |
| 3 |
DaVita
DVA
|
$15.1M |
| 4 |
Universal Health Services
UHS
|
$3.66M |
Top Sells
| 1 |
Elevance Health
ELV
|
$28.9M |
| 2 |
Centene
CNC
|
$28.7M |
| 3 |
Boston Scientific
BSX
|
$22.3M |
| 4 |
McKesson
MCK
|
$21.6M |
| 5 |
Molina Healthcare
MOH
|
$15.8M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Cencora
COR
$57.2B
| $35.3M | 19.27% |
+384,697
| New | +$35.3M |
|
|
2
Elevance Health
ELV
$72.6B
| $30.3M | 16.52% |
134,554
-128,610
| -49% | -$28.9M |
|
|
3
Universal Health Services
UHS
$11.6B
| $26.9M | 14.66% |
236,979
+32,282
| +16% | +$3.66M |
|
|
4
Molina Healthcare
MOH
$9.93B
| $25.4M | 13.84% |
330,747
-206,445
| -38% | -$15.8M |
|
|
5
CVS Health
CVS
$94B
| $24.5M | 13.35% |
+337,537
| New | +$24.5M |
|
|
6
Boston Scientific
BSX
$158B
| $19.7M | 10.74% |
793,865
-900,501
| -53% | -$22.3M |
|
|
7
DaVita
DVA
$9.79B
| $15.1M | 8.24% |
+209,130
| New | +$15.1M |
|
8
Travere Therapeutics
TVTX
$1.62B
| $6.19M | 3.38% |
293,923
| – | – |
|
|
9
Centene
CNC
$14.5B
| – | – |
-296,731
| Closed | -$28.7M |
|
|
10
McKesson
MCK
$86B
| – | – |
-140,372
| Closed | -$21.6M |
|
11
SPDR S&P 500 ETF Trust
SPY
$653B
| – | – |
-55,000
| Closed | -$13.8M |
|
12
Teladoc Health
TDOC
$1.35B
| – | – |
-160,011
| Closed | -$5.3M |
|
13
SPDR S&P Biotech ETF
XBI
$5.25B
| – | – |
-115,821
| Closed | -$10M |
|